Products for Research Use Only
RegisterLogin

Ublituximab

CAT: 0804-HY-P99538-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99538-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects[1].
CAS Number
1174014-05-1
Product Name Alternative
LFB-R603; TG-1101; TGTX-1101
UNSPSC
12352203
Target
CD20
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ublituximab.html
Purity
98.42
Solubility
10 mM in DMSO
Smiles
[Ublituximab]
Molecular Weight
(144.18 kDa)
References & Citations
[1]Matthew Lunning, et al. Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 2019 Nov 21;134 (21) :1811-1820.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
T76966-01Ublituximab
GTR18337804-01Ublituximab Antibody
592282Ublituximab (MS4A1, CD20)
KBI1709KRIBIOLISA™ Ublituximab ELISA
C00568-1mg*5Ublituximab (Anti-CD20)
HY257066-01Research Grade Ublituximab
E55B0315Ublituximab (Reference antibody)
048062CD20 (ublituximab) discontinued
ICH5297-20mgUblituximab Biosimilar - Research Grade
GTR18697934-01Ublituximab Chimeric Monoclonal Antibody

Popular Products